Polypharmacy and pharmacogenomics in high-acuity behavioral health care for autism spectrum disorder: a retrospective study

Polypharmacy and pharmacogenomics in high-acuity behavioral health care for autism spectrum disorder: a retrospective study

Abstract Background This study evaluated pharmacogenomic (PGx) testing in children and adolescents with autism spectrum disorder (ASD). ASD frequently presents with co-occurring depression and anxiety. This complex phenotype often results in psychotropic medication polypharmacy. Incorporating PGx te...

Full description

Saved in:
Bibliographic Details
Main Authors: Sheldon R. Garrison, Sophie A. Schweinert, Matthew W. Boyer, Maharaj Singh, Sreya Vadapalli, Jeffery M. Engelmann, Rachel A. Schwartz, Madeline M. Hartig
Format: Article
Language:English
Published: BMC 2025-05-01
Series:Child and Adolescent Psychiatry and Mental Health
Subjects:
Autism
CYP2D6
ASD
Depression
Anxiety
Pharmacogenomics
Online Access:https://doi.org/10.1186/s13034-025-00915-3
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s13034-025-00915-3

Similar Items